When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Gangrene

Last reviewed: 12 Dec 2025
Last updated: 14 May 2025

Summary

Definition

History and exam

Key diagnostic factors

  • pain
  • edema or swelling
  • skin discoloration
  • crepitus (gas gangrene)
Full details

Other diagnostic factors

  • diminished pedal pulses and ankle-brachial index (ischemic gangrene)
  • low-grade fever and chills (infectious gangrene)
Full details

Risk factors

  • diabetes mellitus
  • atherosclerosis (ischemic gangrene)
  • smoking (ischemic gangrene)
  • renal disease
  • drug and alcohol abuse
  • malignancy
  • trauma or abdominal surgery (infectious gangrene)
  • contaminated wounds (infectious gangrene)
  • immunosuppression (infectious gangrene)
  • malnutrition (infectious gangrene)
  • hypercoagulable states (ischemic gangrene)
  • prolonged application of tourniquets (ischemic gangrene)
  • community-acquired MRSA
Full details

Diagnostic tests

1st tests to order

  • CBC
  • comprehensive metabolic panel
  • serum LDH
  • coagulation panel
  • blood cultures
  • serum CRP
  • plain x-rays
  • CT of affected site
  • MRI of affected site
  • Doppler ultrasonography
Full details

Tests to consider

  • surgical exploration and skin biopsy
  • CT angiography
  • magnetic resonance angiography (MRA)
  • CT chest and abdomen
  • antinuclear antibodies (ANA), lupus anticoagulant, anticardiolipin, and anti beta2 glycoprotein-1 antibodies
  • serum cold agglutinins
  • serum cryofibrinogens
  • plasma cryoglobulin
Full details

Treatment algorithm

INITIAL

necrotizing fasciitis awaiting confirmation of microbial culture and sensitivity results

ACUTE

confirmed type I necrotizing fasciitis (polymicrobial)

confirmed type II necrotizing fasciitis (monomicrobial)

gas gangrene

ischemic gangrene

Contributors

Authors

Jason Jacob, MD

Attending Physician

Assistant Director

Department of Medicine

Hartford Hospital

Hartford

CT

Disclosures

JJ declares that he has no competing interests.

Robert J. Gionfriddo, DO

Assistant Director

Department of Medicine

Hartford Hospital

Hartford

CT

Disclosures

RJG declares that he has no competing interests.

Acknowledgements

Dr Jason Jacob and Dr Robert J. Gionfriddo would like to gratefully acknowledge Dr William Tennant, Dr Badr Aljabri, Dr Mohammed Al-Omran, Dr Jose Contreras-Ruiz, and Dr Iris Galvan-Martinez, the previous contributors to this topic.

Divulgaciones

WT, BA, MA, JC, and IG declare that they have no competing interests.

Revisores por pares

Meryl Davis, MD

Consultant Vascular Surgeon

Royal Free Hampstead

London

UK

Divulgaciones

MD declares that she has no competing interests.

Charles Fox, MD

Vascular Surgeon

Department of Surgery

Walter Reed Army Medical Center

Washington

DC

Divulgaciones

CF declares that he has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Kihiczak GG, Schwartz RA, Kapila R. Necrotizing fasciitis: a deadly infection. J Eur Acad Dermatol Venereol. 2006 Apr;20(4):365-9.Texto completo  Resumen

Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014 Jul 15;59(2):e10-52.Texto completo  Resumen

Nicolasora N, Kaul DR. Infectious disease emergencies. Med Clin North Am. 2008 Mar;92(2):427-41. Resumen

Bradbury AW, Adam DJ, Bell J, et al; BASIL trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg. 2010 May;51(5 Suppl):5-17S. Resumen

Norgren L, Hiatt WR, Dormandy JA, et al.; TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007 Jan;45 Suppl S:S5-67.Texto completo  Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Gangrene images
  • Diferenciales

    • Staphylococcal skin lesions
    • Erysipelas
    • Cellulitis
    Más Diferenciales
  • Guías de práctica clínica

    • 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the management of lower extremity peripheral artery disease
    • Surgical site infections: prevention and treatment
    Más Guías de práctica clínica
  • Folletos para el paciente

    Diabetes: what is it?

    Diabetes type 2: should I take insulin?

    Más Folletos para el paciente
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad